Home Members Only Search About Us Store FASEB Member Directory

 the-aps.org>meetings>eb

advertising
awards
careers and mentoring
chapters
committees
education
meetings
membership
news archives
press room
public affairs
publications
sections and groups
sites of interest
trainees

9560 rockville pike, bethesda, MD 20814-3991
 

 


Stem Cell in Physiology and Drug Discovery
Sponsored by APS Liaison with Industry Committee
Translational Physiology Track

Sunday, April 29 — 10:30 AM-12:30 PM
Washington, DC Convention Center — Room 145A
 
Chaired:

Chahrzad Montrose-Rafizadeh, Eli Lilly and Company, Inc.
Brigid Hogan, Duke Univ.

Research into the isolation and use of stem cells is accelerating rapidly and has broad application in a variety of areas. Stem cells hold great promise in research into basic cell physiology, in studying pathways of cellular differentiation, as tools in drug discovery, and in regenerative medicine. In this symposium the invited speakers will present their latest findings in stem cell research. Dr. Allsopp will review his latest efforts in expanding human stem cells and in their use in studying basic physiological processes. Dr. John McNeish will discuss the use of stem cells in target identification and validation as well as in the drug screening. Dr. Aaron Chuang will focus on stem cells in neurodegeneration. Finally, Dr. Betty Yan will give us an insight on Protein C pathway discovery using human stem cells.

10:30 AM

Stem cells and new medicines: unleashing the potential to realize the expectation.
Timothy E. Allsopp, Stem Cell Sciences PLC, Edinburgh, UK
 

11:00 AM

Pharmacology applications for stem cells in drug discovery.
John McNeish
, Pfizer Global Research & Development, Groton, CT
 

11:30 AM

Manipulating stem cells physiology for neurodegenerative disease therapy.
Aaron T. Chuang, GlaxoSmith Kline, Essex, UK
 

12:00 PM

Protein C pathway in human endothelial progenitor cells (EPCs) isolated from cord blood.
Sau Chi Betty Yan, Eli Lilly and Company, Inc., Indianapolis